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Health in Action
N
ews stories about new 
treatments, tests, products, and 
procedures appear daily. Such 
reporting should ideally be accurate, 
balanced, and complete so that health 
care consumers are properly informed 
and ready to participate in decision 
making about their health care. If 
reporting is inaccurate, imbalanced, 
or incomplete, consumers may have 
unrealistic expectations and demand of 
their physicians care that would be of 
little value or even harmful. 
Is the news media doing a good 
job of reporting on new treatments, 
tests, products, and procedures? Ray 
Moynihan and colleagues analyzed 
how often news stories quantiﬁ  ed 
the costs, beneﬁ  ts, and harms of the 
interventions being discussed, and how 
often they reported potential conﬂ  icts 
of interest in story sources [1]. Of the 
207 newspaper and television stories 
that they studied, 83 did not report the 
beneﬁ  ts of medications quantitatively, 
and of the 124 stories that did quantify 
the beneﬁ  ts of medications, only 18 
presented both relative and absolute 
beneﬁ  ts. Of all the stories, 53% had 
no information about potential harms 
of the treatment, and 70% made 
no mention of treatment costs. Of 
170 stories that cited an expert or 
a scientiﬁ  c study, 85 (50%) cited at 
least one with a ﬁ  nancial tie to the 
manufacturer of the drug, a tie that 
was disclosed in only 33 of the 85 
stories. 
Moynihan and colleagues’ work was 
one of the inspirations for the creation 
of the Australian Media Doctor Web 
site (http://www.mediadoctor.org.au/) 
in 2004. That project monitors the 
health news coverage of 13 Australian 
news organizations. The project 
concluded, after its ﬁ  rst six months 
experience, that “Australian lay news 
reporting of medical advances…is 
poor” [2].
In Canada, Alan Cassels and 
colleagues documented similar 
journalistic shortcomings [3]. Cassels 
heads a team that launched a Canadian 
Media Doctor Web site (http://www.
mediadoctor.ca/) in 2005. That project 
evaluates health news coverage by 12 
Canadian news organizations.
These efforts helped inspire a 
project to evaluate United States 
health news coverage of claims made 
about treatments, tests, products, and 
procedures. HealthNewsReview.org 
started publishing evaluations of health 
news stories in April 2006. The sole 
support for the project is a grant from 
the 501c3 nonproﬁ  t Foundation for 
Informed Medical Decision Making 
(http://www.ﬁ  mdm.org/about.php), 
founded in 1989 by Dartmouth’s Dr. 
Jack Wennberg and colleagues, with 
a mission of “assuring that people 
understand their choices and have the 
information they need to make sound 
decisions affecting their health and well 
being.”
This article reports on the project’s 
ﬁ  ndings after its ﬁ  rst 22 months and 
after evaluation of 500 health news 
stories. 
The HealthNewsReview.org 
Project
HealthNewsReview.org monitors 
news coverage by the top 50 most 
widely circulated newspapers in the 
US; the most widely used wire service, 
the Associated Press; and the three 
leading newsweekly magazines—TIME, 
Newsweek, and U.S. News & World Report. 
Each weekday we watch the morning 
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Summary Points
•  The daily delivery of news stories 
about new treatments, tests, 
products, and procedures may have 
a profound—and perhaps harmful—
impact on health care consumers. 
•  A US Web site project, 
HealthNewsReview.org (http://
HealthNewsReview.org/), modeled 
after similar efforts in Australia and 
Canada, evaluates and grades health 
news coverage, notifying journalists of 
their grades. 
•  After almost two years and 500 stories, 
the project has found that journalists 
usually fail to discuss costs, the quality 
of the evidence, the existence of 
alternative options, and the absolute 
magnitude of potential beneﬁ  ts and 
harms. 
•  Reporters and writers have been 
receptive to the feedback; editors and 
managers must be reached if change is 
to occur. 
•  Time (to research stories), space (in 
publications and broadcasts), and 
training of journalists can provide 
solutions to many of the journalistic 
shortcomings identiﬁ  ed by the project. PLoS Medicine  |  www.plosmedicine.org 0701 May 2008  |  Volume 5  |  Issue 5  |  e95
and evening newscasts of the three 
most watched television networks—
ABC, CBS, and NBC. 
In order to be eligible for review, a 
story must include a claim of efﬁ  cacy 
or safety in a health care product or 
procedure (drug, device, diagnostic 
or screening test, surgical procedure, 
dietary recommendation, vitamin, 
supplement). 
The rating instrument used 
(http://www.healthnewsreview.org/
ratings_info.php) includes ten criteria 
used by the Australian and Canadian 
Media Doctor sites. All of the criteria 
are addressed in the Association of 
Health Care Journalists’ Statement of 
Principles [4]. As seen in the methods 
of evaluation listed in Box 1, each story 
is evaluated on whether it has met the 
ten criteria. 
For each criterion, the story is given a 
rating of “satisfactory,” “unsatisfactory,” 
or “not applicable.” Three reviewers—
with backgrounds in medicine, health 
services research, public health, or 
journalism—analyze each article. (All 
reviewers are listed online at: http://
www.healthnewsreview.org/people.
php.) As the publisher of the project, 
I am always the third reviewer of each 
story, and I mediate any disagreements 
between the ﬁ  rst two reviewers, gaining 
consensus before publishing the ﬁ  nal 
evaluation of the health story. 
Inter-reviewer reliability was tested 
using a random sample of 30 stories. 
Two reviewers coded each story. The 
average percent agreement between 
the two reviewers across the ten ratings 
criteria was 74%. 
Results and Impact of the Project 
to Date
In our evaluation of 500 US health 
news stories over 22 months, between 
62%–77% of stories failed to adequately 
address costs, harms, beneﬁ  ts, the 
quality of the evidence, and the 
existence of other options when 
covering health care products and 
procedures (Table 1). This high rate of 
inadequate reporting raises important 
questions about the quality of the 
information US consumers receive 
from the news media on these health 
news topics.
At a time when US health care 
spending now represents 16% of the 
gross domestic product [5], only 23% 
of the health news stories that we 
analyzed covered the costs of medical 
1. Adequately  discusses  costs. 
We believe that, in an era when 
health care spending represents 16% 
of the US gross domestic product, 
a story is incomplete if it does not 
address the costs of an approach, 
and a comparison with existing 
alternatives. We also think journalists 
should explore whether insurers are 
likely to pay for it. 
2.   Quantiﬁ  es beneﬁ  ts.
Stories should give some sense of the 
size of the potential beneﬁ  ts of the 
approach being discussed. Stories 
(and studies, for that matter) should 
also explain the beneﬁ  ts in absolute, 
not just relative, terms. 
3.  Adequately explains and quantiﬁ  es 
potential harms.
Stories should give a complete 
picture of potential harms of an 
approach, and quantify those 
potential harms in absolute terms. 
4.  Compares the new idea with 
existing alternatives. 
We expect that a story would put the 
new approach being discussed into 
the context of existing alternatives, 
with some discussion of the possible 
advantages or disadvantages of 
the new approach compared with 
existing alternatives. 
5.  Seeks out independent sources 
and discloses potential conﬂ  icts of 
interest. 
We expect, just as the Association 
of Health Care Journalists does, that 
journalists should “recognize that 
most stories involve a degree of 
nuance and complexity that no single 
source could provide. To reﬂ  ect only 
one perspective of only one source 
is not wise; [journalists should] be 
vigilant in selecting sources, asking 
about, weighing and disclosing 
relevant ﬁ  nancial, advocacy, personal 
or other interests of those [they] 
interview as a routine part of story 
research and interviews”[4].
6. Avoids  disease  mongering.
This criterion is an attempt to help 
journalists avoid promulgating the 
medicalization of normal states of or 
variations in health (e.g., baldness, 
menstruation, short stature, etc.). We 
also try to educate journalists about 
surrogate endpoints and about how 
risk factors are not diseases. With 
this criterion, we also remind them 
not to exaggerate the prevalence or 
incidence of a condition. 
7.  Reviews the study methodology or 
the quality of the evidence. 
The story should reﬂ  ect an 
understanding that not all studies 
are equal. If a story does not point 
out some of the limitations of 
an observational study and does 
not caution about interpreting 
uncontrolled data, for example, we 
will judge it unsatisfactory. 
8.  Establishes the true novelty of the 
idea
Many “new” products or procedures 
are not really novel. The product 
reported may be the sixth new 
member of a well-established class 
of drugs. It may be a device that has 
only been judged to be substantially 
equivalent to other devices already 
on the market. Journalists should 
accurately reﬂ  ect the novelty (or 
lack thereof) of “new” products or 
procedures. 
9.  Establishes the availability of the 
product or procedure. 
Many stories report on products or 
procedures that are still in clinical 
trials. We expect journalists to explain 
whether something is only available 
via limited access in clinical trials, 
whether something is FDA approved, 
whether insurability limits availability, 
etc. Many news stories seem to treat 
FDA approval of an investigational 
drug as a fait accompli, making 
predictions about how the drug 
“could be” or “should be” approved 
and on the market within a given 
time frame. Such stories would be 
rated as unsatisfactory. 
10. Appears not to rely solely or largely 
  on a news release. 
  We expect, just as the Association 
  of Health Care Journalists does, that 
  journalists should “Preserve 
  journalistic independence by 
  avoiding the use of video news 
  releases or the use of quotes from 
  printed news releases; label and 
  credit the source whenever a portion 
  of a video or printed news release 
  is used” [4]. We expect a journalist 
  to use a news release for background 
  information only, and to then seek 
  independent experts to comment on 
 a  development. 
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treatments adequately. In an era when 
most news organizations reported on 
postmarketing problems found with 
rofecoxib (Vioxx), coronary stents, or 
hormone replacement therapy, many 
of those same news organizations 
still fail to adequately quantify the 
harms and beneﬁ  ts of the products 
they report on today. Only 28% of the 
stories we evaluated adequately covered 
beneﬁ  ts, and only 33% adequately 
covered harms. 
Many newsrooms across the US 
have eliminated health and medical 
reporting positions because of a drop 
in proﬁ  ts [6]. Those cutbacks may be 
the reason why only 35% of stories we 
evaluated were rated satisfactory on the 
criterion of whether the reporter had 
discussed the study methodology and 
the quality of the evidence, issues that 
only a trained health journalist could 
be expected to understand. 
Only 38% of stories were rated 
satisfactory for putting the intervention 
under discussion into the context 
of existing alternative options. 
The Statement of Principles of the 
Association of Health Care Journalists 
[4] urges journalists to disclose relevant 
conﬂ  icts of interests in their sources 
“as a routine part” of their work, and 
to “avoid single-source stories.” Our 
analysis shows that journalists are 
following this professional guideline 
only about half the time. Examples 
of problems found in stories scoring 
poorly are provided in Box 2. Of 
the ﬁ  rst 500 stories reviewed, 41 
(8%) received our highest scores. 
They appear online at http://www.
healthnewsreview.org/ﬁ  veStars.php. 
Next Steps
We are working to communicate these 
ﬁ  ndings to news organizations and 
to editorial decision makers, and to 
help them see that they often deliver 
an imbalanced picture of health care 
interventions. We believe this imbalance 
may have a profound impact on the 
decision making of American consumers 
who rely on these news stories. 
When we evaluate a health news 
story, we e-mail the evaluation to 
the journalist who wrote that story, 
and their responses have been 
overwhelmingly positive. “It’s quite 
sobering to read the reviews,” wrote 
one journalist. “I imagine you’ve heard 
all the laments from reporters, but the 
lack of both space and research time 
is enormously frustrating (and will 
probably drive me out of journalism in 
the end).” Time and space can provide 
answers to many of the shortcomings 
we identiﬁ  ed. Reporters who are given 
more time to research a topic and more 
space or time in their publications 
or broadcasts would be better able to 
address the criteria that we—and their 
own industry principles—state are 
important. 
Some news organizations choose 
to offer “health headlines,” “medical 
minutes,” or “science briefs”—
presumably to show the breadth of 
their coverage. But our analysis suggests 
that so much is left out in these short 
items that it is difﬁ  cult to convey any 
of the nuance that is so important in 
almost all such stories. We take the 
position that if a news organization 
cannot give sufﬁ  cient space or time to 
a story to cover the necessary issues, 
then it would be better if the story 
were not published or broadcast at all. 
Incomplete stories that lack context 
can cause harm. People may be misled, 
become anxious, or make ill-informed 
decisions based on such stories. 
Training opportunities have been 
slashed in many newsrooms [7]. A 
survey of Midwestern newspapers 
showed that nearly all reporters 
covering health news had received no 
training in this subject matter or in 
interpreting health statistics; of those, 
most said that such training would 
be helpful [8]. Many different forms 
of health care journalism training 
opportunities are now available. 
The National Institutes of Health, 
the Centers for Disease Control and 
Prevention, the Knight Foundation, 
the Association of Health Care 
Journalists, and several universities now 
offer specialized training programs of 
varying lengths, degrees of complexity, 
and formats. 
We observed what we considered to 
be incomplete coverage in some of the 
nation’s top news organizations, and 
gave some of our top scores to stories 
in what might be called second-tier 
newspapers. These observations suggest 
that attaining excellence in health news 
stories is not just an issue of resources. 
While our project is in no way 
a complete analysis of the work 
done over 22 months by the news 
organizations we examined, it 
nonetheless represents the largest 
dynamic database of content analysis 
of US health news coverage ever 
assembled, and it continues to grow 
daily. It provides the clearest picture 
yet available of how major newspapers, 
magazines, and television networks 
cover treatments, tests, products, and 
procedures. And this is the ﬁ  rst project 
that gives journalists regular feedback 
on how they cover health news stories. 
We think that our project’s ﬁ  ndings 
should be a cause for reﬂ  ection by all 
parties involved in the dissemination 
of news and information to journalists 
covering health and medicine—
including medical journals, government 
agencies, industry, academic medical 
centers, and individual clinicians and 
researchers. Some have described 
sensationalism in medical science 
stories as the byproduct of a complicit 
collaboration between journalists and 
scientists [9], wherein journalists ﬁ  nd it 
easier to get attention for their stories 
and scientists see “the practical value of 
media attention to a successful scientiﬁ  c 
career” [9]. Rather than allowing 
the interests of the two professions 
to inﬂ  uence each another in such an 
unhealthy manner, we suggest that 
each should examine its core ethical 
principles. 
One study, by Steve Woloshin and 
Lisa Schwartz, showed that news 
releases from medical journals “do not 
Table 1. Percentage of Satisfactory Reviews for 10 Criteria for 500 Stories 
Criteria (Did the Story Adequately…?) % Satisfactory
Discuss costs 23%
Quantify beneﬁ  ts 28%
Quantify harms 33%
Discuss existing alternative options 38%
Seek independent sources and explore conﬂ  icts of interests in sources 56%
Avoid disease mongering 70%
Discuss quality of the evidence 35%
Establish the true novelty of the approach 85%
Discuss availability of the new approach 70%
Go beyond a news release 65%
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routinely highlight study limitations or 
the role of industry funding. Data are 
often presented using formats that may 
exaggerate the perceived importance 
of ﬁ  ndings” [10]. Vikki Entwistle 
showed how “the way information 
ﬂ  ows from medical journals to 
newspapers inﬂ  uences the balance of 
medical topics reported, the quality 
of the research reported (and its 
appropriateness for public attention), 
and the quality of news reporting” [11].
We hope that our evaluation of health 
news will lead news organizations—and 
all who engage in the dissemination of 
health news and information—to re-
evaluate their practices to better serve 
a more informed health care consumer 
population.  
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